Literature DB >> 32083733

Nonparametric estimation of distributions and diagnostic accuracy based on group-tested results with differential misclassification.

Wei Zhang1, Aiyi Liu2, Qizhai Li1, Paul S Albert3.   

Abstract

This article concerns the problem of estimating a continuous distribution in a diseased or nondiseased population when only group-based test results on the disease status are available. The problem is challenging in that individual disease statuses are not observed and testing results are often subject to misclassification, with further complication that the misclassification may be differential as the group size and the number of the diseased individuals in the group vary. We propose a method to construct nonparametric estimation of the distribution and obtain its asymptotic properties. The performance of the distribution estimator is evaluated under various design considerations concerning group sizes and classification errors. The method is exemplified with data from the National Health and Nutrition Examination Survey study to estimate the distribution and diagnostic accuracy of C-reactive protein in blood samples in predicting chlamydia incidence.
© 2020 The International Biometric Society.

Entities:  

Keywords:  ROC curves; coverage probability; diagnostic accuracy; differential misclassification; group testing; integrated absolute bias; integrated mean squared error; rare disease

Mesh:

Year:  2020        PMID: 32083733      PMCID: PMC8581970          DOI: 10.1111/biom.13236

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   1.701


  18 in total

1.  Regression analysis of group testing samples.

Authors:  M Xie
Journal:  Stat Med       Date:  2001-07-15       Impact factor: 2.373

2.  Robustness of group testing in the estimation of proportions.

Authors:  M Hung; W H Swallow
Journal:  Biometrics       Date:  1999-03       Impact factor: 2.571

3.  Optimality of group testing in the presence of misclassification.

Authors:  Aiyi Liu; Chunling Liu; Zhiwei Zhang; Paul S Albert
Journal:  Biometrika       Date:  2011-12-29       Impact factor: 2.445

4.  Two-stage hierarchical group testing for multiple infections with application to the infertility prevention project.

Authors:  Joshua M Tebbs; Christopher S McMahan; Christopher R Bilder
Journal:  Biometrics       Date:  2013-10-04       Impact factor: 2.571

5.  Misclassified group-tested current status data.

Authors:  L C Petito; N P Jewell
Journal:  Biometrika       Date:  2016-12-08       Impact factor: 2.445

6.  The role of serological testing for Chlamydia trachomatis in differential diagnosis of pelvic pain.

Authors:  Beata Łój; Agnieszka Brodowska; Sylwester Ciecwiez; Iwona Szydłowska; Jacek Brodowski; Marek Łokaj; Andrzej Starczewski
Journal:  Ann Agric Environ Med       Date:  2016-09       Impact factor: 1.447

7.  Comparing urine samples and cervical swabs for Chlamydia testing in a female population by means of Strand Displacement Assay (SDA).

Authors:  Siren Haugland; Turid Thune; Beata Fosse; Tore Wentzel-Larsen; Stig Ove Hjelmevoll; Helge Myrmel
Journal:  BMC Womens Health       Date:  2010-03-25       Impact factor: 2.809

8.  Hierarchical group testing for multiple infections.

Authors:  Peijie Hou; Joshua M Tebbs; Christopher R Bilder; Christopher S McMahan
Journal:  Biometrics       Date:  2016-09-22       Impact factor: 2.571

9.  Group testing regression model estimation when case identification is a goal.

Authors:  Boan Zhang; Christopher R Bilder; Joshua M Tebbs
Journal:  Biom J       Date:  2013-02-08       Impact factor: 2.207

10.  Clinical characteristics of genital chlamydia infection in pelvic inflammatory disease.

Authors:  Sung Taek Park; Suk Woo Lee; Min Jeong Kim; Young Mo Kang; Hye Min Moon; Chae Chun Rhim
Journal:  BMC Womens Health       Date:  2017-01-13       Impact factor: 2.809

View more
  2 in total

1.  Nested Group Testing Procedure.

Authors:  Wenjun Xiong; Juan Ding; Wei Zhang; Aiyi Liu; Qizhai Li
Journal:  Commun Math Stat       Date:  2022-10-01

2.  Group testing can improve the cost-efficiency of prospective-retrospective biomarker studies.

Authors:  Wei Zhang; Zhiwei Zhang; Julia Krushkal; Aiyi Liu
Journal:  BMC Med Res Methodol       Date:  2021-03-19       Impact factor: 4.615

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.